Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With &lt;i&gt;RAS/BRAF&lt;/i&gt; Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
SWOG Cancer Research Network
Kanwal Pratap Singh Raghav; Katherine A Guthrie; Benjamin Tan; Crystal S Denlinger; Marwan Fakih; Michael J Overman; N Arvind Dasari; Larry R Corum; Lee G Hicks; Mital S Patel; Benjamin T Esparaz; Syed M Kazmi; Nitya Alluri; Sarah Colby; Sepideh Gholami; Philip J Gold; E Gabriela Chiorean; Scott Kopetz; Howard S Hochster; Philip A Philip
SWOG Statistics and Data Management Center, Seattle, WA. ; SWOG Statistics and Data Management Center, Seattle, WA.